Employee Spotlight: Dan Inglese, Research Associate

  Highlighting our dedicated employees who bring both their experience and passions to Imagion Biosystems:  What experience do you bring prior to joining…


MagSense® HER2 Breast Cancer First-in-human Study Progress Update

Imagion Biosystems Limited (ASX: IBX) is pleased to provide an update on the progress of its first-in-human study for the MagSense® HER2 breast cancer imaging…


Imagion Biosystems 2021 Full Year Results

Imagion Biosystems has released its Annual Report for the year ended 31 December 2021. See linked documents below. 2021 Clinical Highlights:  Multiple…


Quarterly Activity Report and Appendix 4C for 31 December 2021

Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 31 December 2021. The announcement highlights a recap of the…


Imagion Bio at The Edison Open House: Global Healthcare 2022

Our CEO, Bob Proulx, connected with the Edison Group during their Global Healthcare Open House to discuss in detail, the nanotechnology behind our bio-imaging…


Biotech Daily — Dr Boreham's Crucible: Imagion Biosystems

Tim Boreham revisits Imagion Biosystems' potential in this 5-1/2 page article profiling the company and discussing its recent milestones. Read the article…


Imagion Biosystems December 2021 Investor Newsletter

We are pleased to provide our investors with our December 2021 Investor Newsletter. In this edition, our Executive Director and CEO Bob Proulx gives an…


Employee Spotlight: Carmen Soikowski, Director of Operations

Highlighting our dedicated employees who bring both their experience and passions to Imagion Biosystems:  We sat down with Carmen Soikowski, who joined us as…


IBXO Options Exercise Complete

Imagion Biosystems is pleased to advise that it has now received the full $4.8 million from the exercise of all 96,706,395 listed options (IBXO) which had an…


Magnetic Nanoparticles as Imaging Agents Presentation at the 2021 VBIC Meeting

As a sponsor of the 2021 Annual VBIC Network Meeting, Imagion Biosystems' President and CEO, Bob Proulx, gave a presentation on magnetic nanoparticles as…